カレトラかぁ。 Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment... - PubMed - NCBI https://t.co/unoQ45ECjP
Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Feb 2020 – Mar 2020Where it's discussed
-
X / Twitter17 posts
-
News11 articles
-
YouTube3 videos
AI synopsis
What people are saying
The overall tone reflects cautious support and curiosity, with discussions referencing the study's details such as the effectiveness of lopinavir/ritonavir in reducing viral loads and the significance of tertiary transmission cases, emphasizing its relevance during the early stages of the pandemic. Words like 'potential,' 'significant decrease,' and 'important case' underscore a moderate agreement and a serious interest in clinical insights.
Most discussions acknowledge the potential effectiveness of lopinavir/ritonavir in treating COVID-19 pneumonia, showing moderate agreement with the study's findings.
Participants display a cautious but genuine interest, mainly focusing on the clinical implications and relevance of the research.
The posts demonstrate active engagement by referencing specific details from the publication and considering its significance within the COVID-19 treatment landscape.
The conversations suggest a meaningful impact with some users highlighting the importance of this case study in understanding transmission and treatment efficacy.
Abstract in brief
- The case involves a 54-year-old male in South Korea who was the third confirmed COVID-19 patient and caused secondary and tertiary transmissions, highlighting the virus's rapid spread.
- The patient experienced mild respiratory symptoms initially, with pneumonia developing by day 6 of hospitalization, and his clinical course included transmission to others outside China.
- The study reports that treatment with lopinavir-ritonavir (Kaletra) was associated with a significant decrease in viral loads, suggesting it may be effective in managing COVID-19 pneumonia.]
Top posts
Most liked on X and Bluesky新型コロナ(COVID 19)に関して、 カレトラを使用した症例報告は論文として出たみたいやね。韓国の事例。 https://t.co/DelzbgYsvP
Core Pubmed: Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative… https://t.co/PiYqsa24Qh #coronavirus #SARS_CoV_2 #covid19
Letter to the Editor: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR - JKMS https://t.co/YomiKSmgJh
Trending on PubMed: Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR. https://t.co/x5OSRW2EdG
RT @PaperbirdsH: New article: Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of…
All mentions
Impacts of Climate Change on Marine Biodiversity
This video explores the impacts of climate change on marine biodiversity. It discusses key findings on species adaptation, habitat loss, and conservation strategies in the face of rising temperatures and ocean…
COVID-19 Transmission Case and Lopinavir/Ritonavir Treatment Effectiveness
This case involves a 54-year-old South Korean male, the third confirmed COVID-19 patient, causing secondary and tertiary transmissions, highlighting rapid spread. Treatment with lopinavir-ritonavir showed a significant…
Analysis of COVID-19 Transmission and Treatment with Lopinavir-Ritonavir in Korea
This video examines a 54-year-old male COVID-19 case in South Korea, highlighting rapid virus spread and the potential effectiveness of lopinavir-ritonavir therapy in reducing viral loads and managing pneumonia.
Letter to the Editor: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR - JKMS https://t.co/YomiKSmgJh
Core Pubmed: Letter to the Editor: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia… https://t.co/IBLxrIlYi7 #coronavirus #SARS_CoV_2 #covid19
Core Pubmed: Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative… https://t.co/PiYqsa24Qh #coronavirus #SARS_CoV_2 #covid19
https://t.co/AyfK03EnQz https://t.co/L9kUVV7lFU
新型コロナ(COVID 19)に関して、 カレトラを使用した症例報告は論文として出たみたいやね。韓国の事例。 https://t.co/DelzbgYsvP
RT @syuichiao89: カレトラかぁ。 Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lop…
RT @MissSimone: Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Rit…
RT @PaperbirdsH: New article: Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of…
@TomasCaroPaton @el_pais https://t.co/IOZYvmauIJ
New article: The Author's Response: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by… https://t.co/SFcUYQ8Xei #coronavirus #wuhan #2019ncov
New article: Letter to the Editor: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by… https://t.co/Tvwz1v1SMU #coronavirus #wuhan #2019ncov
Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR https://t.co/bikPtp8DQh
RT @DrJHK: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ri…
カレトラかぁ。 Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment... - PubMed - NCBI https://t.co/unoQ45ECjP
Trending on PubMed: Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR. https://t.co/x5OSRW2EdG
Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment o... - PubMed - NCBI https://t.co/1fwO9dsw30
New article: Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR. https://t.co/uLTVztMf65 #coronavirus #wuhan #2019ncov